Talaris Therapeutics, Inc. (TALS) Social Stream



Talaris Therapeutics, Inc. (TALS): $27.20

0.20 (-0.73%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

D

Add TALS to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#127 of 360

in industry

TALARIS THERAPEUTICS INC (TALS) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering TALARIS THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-01 4 $35 $21 $29.25 $2.7 983.33%
2022-01-28 4 $35 $22 $29.5 $2.7 992.59%
2022-03-17 4 $35 $20 $25.75 $2.7 853.7%
2022-03-22 4 $35 $21 $26 $2.7 862.96%
2022-05-12 4 $35 $21 $25.75 $2.7 853.7%
2022-05-24 4 $35 $20 $25.5 $2.7 844.44%
2022-08-24 2 $8 $7 $7.5 $2.7 177.78%
2022-09-09 2 $7 $6 $6.5 $2.7 140.74%
2022-10-24 3 $18 $2 $8.666 $2.7 220.96%
2023-02-16 3 $12 $2 $6.666 $2.7 146.89%
2023-03-31 3 $12 $2 $5.666 $2.7 109.85%
2023-05-16 3 $3 $2 $2.5 $2.7 -7.41%
2023-06-26 2 $3 $3 $3 $2.7 11.11%
NA 1 $NA $NA $NA $2.7 NA%

Price Target Last Issued NA NA, NA

The Trend in the Analyst Price Target


TALS's average price target has moved down $22.75 over the prior 14 months.

Over the past 35 weeks, TALS's average upside potential has been 222.32%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-10-24 3 12 2 6.666 1.49 347.38%
2023-02-23 3 3 3 3.000 1.93 55.44%
2023-02-23 2 3 3 3.000 1.93 55.44%
2023-02-23 3 12 2 5.666 1.93 193.58%
2023-05-16 3 3 2 2.500 2.53 -1.19%

TALS Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 2 0 0 2

The Trend in the Broker Recommendations


TALS's average broker recommendation rating worsened by 1.75 over the prior 15 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • To contextualize these metrics, consider that out of all US stocks, TALARIS THERAPEUTICS INC's number of analysts covering the stock is higher than 149.76% of them.
  • To contextualize these metrics, consider that out of all US stocks, TALARIS THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1279.68% of them.
  • TALARIS THERAPEUTICS INC's average analyst price target is higher than 292.51% of all US stocks.
  • In the context of Pharmaceutical Products stocks, TALARIS THERAPEUTICS INC's variance in analysts' estimates is lower than -449.75% of them.

In the Pharmaceutical Products industry, MOLN, IPSC, and AMAM are the three stocks most similar to TALARIS THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is TALS a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!